| Patient | Duke Kahanamoku |
|---|---|
| Date of birth | 1890-08-24 |
| Identifiers | MRN HR-ML050-SYN-TD; SSN (made up) 000-50-6847 |
| Document date | 1957-03-16 |
| Author | Kawika Lindgren-Morrison, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for establishing care for six weeks of breathlessness, ankle swelling and tiredness five years after a heart attack: examination, ECG, chest X-ray, NT-proBNP and laboratory tests, a diuretic, and the plan for an echocardiogram. [S]
NT-proBNP: 2450 pg/mL (high); Sodium: 138 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 1.02 mg/dL; eGFR (CKD-EPI 1952): 81 mL/min/1.73 m²; Glucose: 102 mg/dL (high); Magnesium: 2 mg/dL; Hemoglobin: 13.4 g/dL; Ferritin: 62 ng/mL (low); Transferrin saturation: 16% (low); TSH: 2.1 mIU/L; Hemoglobin A1c: 5.9% (high); Total cholesterol: 168 mg/dL; LDL cholesterol: 92 mg/dL (high); HDL cholesterol: 44 mg/dL; Triglycerides: 160 mg/dL (high); ALT: 28 U/L; PHQ-2: 1; KCCQ-12 overall summary: 38. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1957-03-16 | Body height | 185 | cm | S |
| 1957-03-16 | Body weight | 97.6 | kg | S |
| 1957-03-16 | Body mass index (BMI) [Ratio] | 28.5 | kg/m2 | S |
| 1957-03-16 | Systolic blood pressure | 142 | mm[Hg] | S |
| 1957-03-16 | Diastolic blood pressure | 86 | mm[Hg] | S |
| 1957-03-16 | Heart rate | 92 | /min | S |
| 1957-03-16 | Respiratory rate | 20 | /min | S |
| 1957-03-16 | Body temperature | 36.7 | Cel | S |
| 1957-03-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 94 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1957-03-16 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma | 2450 | pg/mL | Below 125 pg/mL makes heart failure unlikely outside the hospital | High | S |
| 1957-03-16 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 1957-03-16 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1957-03-16 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1957-03-16 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1952)/1.73 sq M | 81 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1957-03-16 | Glucose [Mass/volume] in Serum or Plasma | 102 | mg/dL | 70-99 mg/dL | High | S |
| 1957-03-16 | Magnesium [Mass/volume] in Serum or Plasma | 2 | mg/dL | 1.6-2.6 mg/dL | Normal | S |
| 1957-03-16 | Hemoglobin [Mass/volume] in Blood | 13.4 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 1957-03-16 | Ferritin [Mass/volume] in Serum or Plasma | 62 | ng/mL | In heart failure, below 100 ng/mL, or 100 to 299 with transferrin saturation below 20%, is iron deficiency | Low | S |
| 1957-03-16 | Iron saturation [Mass Fraction] in Serum or Plasma | 16 | % | 20-50% | Low | S |
| 1957-03-16 | Thyrotropin [Units/volume] in Serum or Plasma | 2.1 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 1957-03-16 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.9 | % | <=5.6% | High | S |
| 1957-03-16 | Cholesterol [Mass/volume] in Serum or Plasma | 168 | mg/dL | <=199 mg/dL | Normal | S |
| 1957-03-16 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 92 | mg/dL | Secondary-prevention goal below 70 mg/dL | High | S |
| 1957-03-16 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 44 | mg/dL | >=40 mg/dL | Normal | S |
| 1957-03-16 | Triglyceride [Mass/volume] in Serum or Plasma | 160 | mg/dL | <=149 mg/dL | High | S |
| 1957-03-16 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 28 | U/L | 7-55 U/L | Normal | S |
| 1957-03-16 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 1957-03-16 | Overall summary score [KCCQ-12] | 38 | {score} | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Aspirin 81 mg delayed-release oral tablet, one tablet daily | One tablet daily | Oral route | 1952-06-21 | active | S |
| Atorvastatin 40 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1952-06-21 to 1957-03-16 | completed | S |
| Atorvastatin 80 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1957-03-16 | active | S |
| Metoprolol tartrate 25 mg oral tablet, one tablet twice daily | One tablet twice daily | Oral route | 1952-06-21 to 1957-03-30 | completed | S |
| Lisinopril 10 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1952-06-21 to 1957-03-30 | completed | S |
| Furosemide 40 mg oral tablet, one tablet every morning | One tablet every morning | Oral route | 1957-03-16 to 1957-04-27 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Breathlessness on exertion for six weeks (paddling out, walking uphill, finishing his morning swim), with ankle swelling by evening and tiredness, five years after a heart attack; cause to be determined | active | confirmed | R06.09 | S — Synthetic presenting problem, resolved at the second visit when the echocardiogram and cardiology established heart failure with reduced ejection fraction. |
| Coronary artery disease with an old anterior myocardial infarction five years ago, treated with medicines; synthetic modern episode linked to the documented heart attack of 1883 | active | confirmed | I25.2 | S — Synthetic modern diagnosis; the 1952 heart attack remains D in the history. |
| Iron deficiency without anemia (ferritin 62 ng/mL, transferrin saturation 16%) | active | confirmed | E61.1 | S — Synthetic finding at the heart failure workup. |